Pharmacodynamics of rocuronium with and without prior administration of succinylcholine

Journal of Clinical Anesthesia

Volumn 7, Issue 1, 1995, Pages 44-48

  Dubois, Michel Y ^a   Lea, Dawn E ^a   Kataria, Bideshwar ^a   Gadde, Prasad L ^a   Tran, Dung Q ^a   Shearrow, Tammy ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intubation, intratracheal; nondepolarizing neuromuscular relaxants; rocuronium; succinylcholine

Indexed keywords

ATRACURIUM; DROPERIDOL; FENTANYL; HALOTHANE; ISOFLURANE; MIDAZOLAM; NITROUS OXIDE; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FASCICULATION; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPERSALIVATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR SYNAPSE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HEART RATE; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE; TIME FACTORS; ULNAR NERVE;

EID: 0028970225     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/0952-8180(94)00002-L     Document Type: Article

References (25)

1. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal non-depolarizing agent
2. The pharmacodynamics and pharmacokinetics of ORG 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl
3. Pharmacodynamic effects of three doses of ORG 9426 used for endotracheal intubation in humans
4. Evaluation of the endotracheal intubating conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery
5. The neuromuscular effects of ORG 9426 in patients receiving balanced anesthesia
6. Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia
7. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and the adductor pollicis
8. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans
9. Neuromuscular effects of succinylcholine on the vocal cords and adductor pollicis muscle
10. Masseteric muscle spasm as a normal response to suxamethonium
11. Comparison of intubating conditions after administration of ORG 9426 (rocuronium) and suxamethonium
12. Intubating conditions and onset of neuromuscular block of rocuronium (ORG 9426); a comparison with suxamethonium
13. A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York
14. Influence of suxamethonium on the action of subsequently administered vecuronium or pancuronium
15. Evolution of vecuronium requirements for stable mechanical effect: comparison with or without previous succinylcholine administration
16. Modification of atracurium blockade by halothane and by suxamethonium A review of clinical experience
17. The effects of succinylcholine on doxacurium-induced neuromuscular blockade
18. Influence of suxamethonium on the potency of ORG NC 45 in anesthetized patients
19. Prejunctional effects of vecuronium in the cat
20. Interaction among agents that block end-plate depolarization competitively
21. The effect of the steroid muscle relaxant pipecuronium bromide on the acetylcholinesterase activity of red blood cells in vitro
22. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium
23. Clinical responses to ORG-9426 during isoflurane anesthesia
24. Evaluation of the time course of action of maintenance doses of rocuronium (ORG 9426) under halothane anaesthesia
25. The neuromuscular blocking effect of ORG-9426. A new intermediate-acting steroidal nondepolarising muscle relaxant in man